{"DataElement":{"publicId":"3282651","version":"1","preferredName":"Malignant Lymphoma First Cancer Progression Other Extranodal Site Text","preferredDefinition":"Name of the extranodal anatomic location of the first progression of malignant lymphoma different from those already specified or mentioned.","longName":"3282639v1.0:3135361v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3282639","version":"1","preferredName":"Malignant Lymphoma First Cancer Progression Other Anatomic Site","preferredDefinition":"(ma-LIG-nant) Cancerous; a growth with a tendency to invade and destroy nearby tissue and spread to other parts of the body._A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas._Preceding all others in time or space or degree._A pathologic process in which alterations at the molecular level result in a more aggressive cytologic and phenotypic profile and clinical course of a malignant neoplasm._Different than the one(s) previously specified or mentioned._Named locations of, or within, the body.","longName":"3233236v1.0:3282637v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3233236","version":"1","preferredName":"Malignant Lymphoma","preferredDefinition":"(ma-LIG-nant) Cancerous; a growth with a tendency to invade and destroy nearby tissue and spread to other parts of the body.:A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","longName":"C14143:C3208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant","conceptCode":"C14143","definition":"Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A263C514-EC43-8796-E040-BB89AD431F1E","latestVersionIndicator":"Yes","beginDate":"2011-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-03","modifiedBy":"ONEDATA","dateModified":"2011-05-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3282637","version":"1","preferredName":"First Cancer Progression Other Anatomic Site","preferredDefinition":"Preceding all others in time or space or degree.:The worsening of a cancer over time.:Different than the one(s) previously specified or mentioned.:Named locations of, or within, the body.","longName":"C25509:C19987:C17649:C13717","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Cancer Progression","conceptCode":"C19987","definition":"A pathologic process in which alterations at the molecular level result in a more aggressive cytologic and phenotypic profile and clinical course of a malignant neoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Anatomic Site","conceptCode":"C13717","definition":"Named locations of or within the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD6513BA-1B7C-8725-E040-BB89AD431A86","latestVersionIndicator":"Yes","beginDate":"2011-09-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-20","modifiedBy":"ONEDATA","dateModified":"2011-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008563","version":"1","preferredName":"Therapy Results","preferredDefinition":"the results or effects (does not include CTC Adverse Events) of therapeutic agents or procedures administered to the patient.","longName":"TX_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6690D31-4081-494A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-06","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-11","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD6513BA-1B8D-8725-E040-BB89AD431A86","latestVersionIndicator":"Yes","beginDate":"2011-09-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Released per approval by B. McClure-Shimel. mc 10/4/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3135361","version":"1","preferredName":"Metastatic Anatomic Site Text","preferredDefinition":"(MET-uh-STAT-ik) Having to do with metastasis, which is the spread of cancer from one part of the body to another._Named locations of, or within, the body._Text; the words of something written.","longName":"3135361v1.0","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008526","version":"1","preferredName":"Anatomic Sites","preferredDefinition":"locations or structures in the human body.","longName":"ANAT_SITES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ED0F8B-4D91-332D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3135360","version":"1","preferredName":"Metastatic Anatomic Site Text","preferredDefinition":"(MET-uh-STAT-ik) Having to do with metastasis, which is the spread of cancer from one part of the body to another.:Named locations of, or within, the body.:Text; the words of something written.","longName":"C14174:C13717:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Anatomic Site","conceptCode":"C13717","definition":"Named locations of or within the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FC1173C-8B12-5FB1-E040-BB89AD432078","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FC1173C-8B23-5FB1-E040-BB89AD432078","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"HARTLEYG","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[{"name":"MLG_LYM_FRT_PRG_TXT","type":"C3D Name","context":"CCR"},{"name":"CCR","type":"USED_BY","context":"CCR"}],"ReferenceDocuments":[{"name":"Other Specified Extranodal Si","type":"Preferred Question Text","description":"Other Specified Extranodal Site of First Malignant Lymphoma Progression","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD659607-E886-D2D3-E040-BB89AD435CA4","latestVersionIndicator":"Yes","beginDate":"2011-09-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-20","modifiedBy":"HARTLEYG","dateModified":"2021-12-13","changeDescription":"Released per approval by B. McClure-Shimel. mc 10/4/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}